Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... commented Steve Shapiro, MD, Professor and Chairman of the Department of Medicine at UniversityofPittsburgh. BronchoGen™ uses easily accessible cells lining the ... Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that its clinical study for BronchoGen™, a diagnostic test for ... I/II Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI). This groundbreaking clinical study is enrolling up to 800 patients at 12 sites in ...
2009 NOV 16 ... in Casa Grande, Ariz., and Adjunct Assistant Professor of Radiation Oncology at the University of Pittsburgh Cancer Institute in Pittsburgh said. "Oncologists can use these results to provide greater patient ...
2009 OCT 19 ... including David Schwartz, MD, at National Jewish Health, Mark Geraci, MD, at the Universityof Colorado Denver's School of Medicine; Naftali Kaminski, MD, and Frank Sciurba, MD, ... School of Medicine; Naftali Kaminski, MD, and Frank Sciurba, MD, at the University of Pittsburgh School of Medicine; John Quackenbush, PhD, at the Dana-Farber CancerInstitute; and ...
2009 OCT 19 ... 2009;30(10):1722-8). For additional information, contact M. Srinivasan, University of Pittsburgh Cancer Institute, Dept. of Epidemiology, Graduate School of Public Health, Pittsburgh, PA 15232 USA.. ...
2009 NOV 1 ... according to researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute (UPCI). The findings, published in the online version of the Journal of Virology, ...
Subject: University of Pittsburgh Schools of the Health Sciences
2009 NOV 2 ... Jerome Bettis. Bettis had a stellar career - first during four years at the Universityof Notre Dame and then 12 years in the National Football League (NFL) with the St. Louis ... and then 12 years in the National Football League (NFL) with the St. Louis Rams and the Pittsburgh Steelers. The tenacity that he displayed on the field and in dealing with his asthma ... including those who need treatments to fight such debilitating chronic diseases as cancer, heart disease, diabetes and asthma. In Pennsylvania alone, there are ... alone, there are millions of cases of chronic diseases, according to the Milken Institute and the Partnership to Fight Chronic Disease. Nationwide, more than 133 million ...
2009 SEP 22 ... and mediate equally potent immune suppression," wrote M. Mandapathil and colleagues, UniversityofPittsburgh. The researchers concluded: "Thus, CD39 surface marker can ... human Treg from the peripheral blood of healthy donors or patients with cancer for studies of their role in health and disease." Mandapathil and ... For additional information, contact T.L. Whiteside, University of Pittsburgh, Institute Cancer, Hillman Cancer Center, 5117 Center Avenue, Suite 1-27, Pittsburgh, PA 15213, ...
2009 SEP 21 ... Additional information can be obtained by contacting M.J. Egorin, University of Pittsburgh Cancer Institute, Molecular Therapeutics, Drug Discovery Program, Pittsburgh, PA 15213-1863 USA.. ...
2009 OCT 19 ... For additional information, contact P. Yan, University of Pittsburgh Medical Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213 USA.. The publisher's contact information for the ...
2009 OCT 5 ... as well as for baseline PLK4 protein stability," wrote N. Korzeniewski and colleagues, UniversityofPittsburgh. The researchers concluded: "Collectively, our results ... of cyclin E/cyclin-dependent kinase 2 activity, as is frequently observed in human cancer cells, as well as for baseline PLK4 protein stability," wrote N. Korzeniewski and ... For more information, contact S. Duensing, University of Pittsburgh, Institute Cancer, Molecular Virology Program, Hillman Cancer Center, Research Pavill Suite 1-8, ...
2009 NOV 1 ... apoptosis) and host (decreased inflammation) effects," wrote X.Y. Liang and colleagues, UniversityofPittsburgh. The researchers concluded: "EP administration may have a ... a protective effect in animal models of inflammation. As inflammation is linked to cancer growth, we hypothesized that EP would have anti-tumor activity and explored its effects ... X.Y. Liang, University of Pittsburgh, UPMC Montefiore, Thomas E Starzl Transplantation Institute, 7 S 3459 5th Avenue, Pittsburgh, PA 15213, USA. The publisher of the ...
2009 NOV 16 ... in HPCs via an RNA-editing dependent mechanism," wrote R. Xufeng and colleagues, UniversityofPittsburgh. The researchers concluded: "Therefore, ADAR1 plays an ... information, contact Q.D. Wang, University of Pittsburgh, School Medical, InstituteCancer, Pittsburgh, PA 15213, USA. The publisher's contact information for the ...
2009 SEP 21 ... in H460 lung cancer cells inhibited metastasis in mice," wrote W. Yue and colleagues, UniversityofPittsburgh, Medical Department. The researchers concluded: ... For additional information, contact L. Zhang, University of Pittsburgh, Institute Cancer, Hillman Cancer Center, School Medical, Dept. of Pharmacology & Chemical Biology, ...
2009 SEP 14 ... of Neurological Surgery, and Director, Minimally Invasive endoNeurosurgery Center at the UniversityofPittsburgh Medical Center (UPMC). In this role, he directed one of the world's ... of the new Saint John's Neuroscience Institute and faculty member of the John Wayne CancerInstitute at Saint John's. Dr. Kassam will lead the development of the new Neuroscience ...
2009 OCT 19 ... 8F1, is not suitable for immunodetection in tissue," wrote N.R. Bhagwat and colleagues, UniversityofPittsburgh. The researchers concluded: "The results with validated ... reveal marked differences in ERCC1-XPF protein levels between samples and cell types. [Cancer Res 2009;69(17):6831-8]." Bhagwat and colleagues published their study in ... For more information, contact L.J. Niedernhofer, University of Pittsburgh, Institute Cancer, Hillman Cancer Center, 5117 Center Avenue, 2-6, Pittsburgh, PA 15213, USA. ...
2009 OCT 19 ... HPV-16 E7-expressing cells but not in control cells," wrote N. Spardy and colleagues, UniversityofPittsburgh. The researchers concluded: "In summary, our results suggest ... deregulation of components of the SCO beta-TrCP-based claspin degradation machinery. [Cancer Res 2009;69(17):7022-9]." Spardy and colleagues published their study in ... For more information, contact S. Duensing, University of Pittsburgh, Institute Cancer, Molecular Virology Program, Hillman Cancer Center, Research Pavil Suite 1-8, ...
2009 NOV 23 ... responses to nicotine versus placebo patch," wrote K.A. Perkins and colleagues, UniversityofPittsburgh, Western Psychiatric Institute. The researchers concluded: ... beta 2 subunit gene may influence therapeutic responsiveness to cessation medications. (Cancer Epidemiol Biomarkers Prev 2009; 18(10):2608-12)." Perkins and colleagues ...
